5 research outputs found
The persistence of papillomavirus infection in women with chronic cervicitis
Were examined and treated of 245 women with chronic cervicitis associated with HPV - infection. The aim of the study was to identify clinical - laboratory criteria for persistence forecast HPV- infection in women with chronic cervicitis. All the patients were divided into two groups: I group consisted of 198 patients who have HPV from cervical canal eliminated within 6 months after treatment, II group - 47 women with persistent HPV infection. Found, that HPV infection in women with chronic cervicitis is persistent over 19% of cases. Patients with persistent HPV infection significantly more likely to have two or more sexual partners during the last year, significantly more likely to have respiratory pathology, endocrine system and diseases of the gastrointestinal tract, often complained of contact bleeding and had burdened heredity of malignant disease of the cervix. Past colposkopical studies indicate that, significantly more likely in patients with persistent HPV detected stippling and iodine the negative zone. Found, that women with persistent HPV significantly more likely chronic inflammation of the cervix combined with dysplasia of the cervix. Higher viral load was significantly more frequently observed in women with persistent HPV infection, even so the persistence observed in patients with chronic inflammation of the cervix associated with 18 types of HPV.ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈ Π»Π΅ΡΠ΅Π½ΠΈΠ΅ 245 ΠΆΠ΅Π½ΡΠΈΠ½ Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ΅ΡΠ²ΠΈΡΠΈΡΠΎΠΌ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ Ρ ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΠ°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ. Π¦Π΅Π»ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ²ΠΈΠ»ΠΎΡΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ
ΠΊΡΠΈΡΠ΅ΡΠΈΠ΅Π² ΠΏΡΠΎΠ³Π½ΠΎΠ·Π° ΠΏΠ΅ΡΡΠΈΡΡΠ΅Π½ΡΠΈΠΈ ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΠ°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ΅ΡΠ²ΠΈΡΠΈΡΠΎΠΌ. ΠΡΠ΅ Π±ΠΎΠ»ΡΠ½ΡΠ΅ Π±ΡΠ»ΠΈ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ: I Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 198 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ, Ρ ΠΊΠΎΡΠΎΡΡΡ
ΠΠΠ§ ΠΈΠ· ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΊΠ°Π½Π°Π»Π° ΡΠ»ΠΈΠΌΠΈΠ½ΠΈΡΠΎΠ²Π°Π» ΡΠ΅ΡΠ΅Π· 6 ΠΌΠ΅ΡΡΡΠ΅Π² ΠΏΠΎΡΠ»Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ, II Π³ΡΡΠΏΠΏΡ - 47 ΠΆΠ΅Π½ΡΠΈΠ½ Ρ ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΡΠ΅ΠΉ ΠΠΠ§-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΠΠ§-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡ Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ΅ΡΠ²ΠΈΡΠΈΡΠΎΠΌ ΠΈΠΌΠ΅Π΅Ρ ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΡΠ΅Π΅ ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ Π² 19% ΡΠ»ΡΡΠ°Π΅Π². ΠΠΎΠ»ΡΠ½ΡΠ΅ Ρ ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΡΠ΅ΠΉ ΠΠΠ§-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ°ΡΠ΅ ΠΈΠΌΠ΅Π»ΠΈ Π΄Π²ΡΡ
ΠΈ Π±ΠΎΠ»Π΅Π΅ ΠΏΠΎΠ»ΠΎΠ²ΡΡ
ΠΏΠ°ΡΡΠ½Π΅ΡΠΎΠ² Π² ΡΠ΅ΡΠ΅Π½ΠΈΠ΅ ΠΏΠΎΡΠ»Π΅Π΄Π½Π΅Π³ΠΎ Π³ΠΎΠ΄Π°, Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ°ΡΠ΅ ΠΈΠΌΠ΅Π»ΠΈ ΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ Π΄ΡΡ
Π°ΡΠ΅Π»ΡΠ½ΠΎΠΉ, ΡΠ½Π΄ΠΎΠΊΡΠΈΠ½Π½ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌ ΠΈ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡ ΠΆΠ΅Π»ΡΠ΄ΠΎΡΠ½ΠΎ-ΠΊΠΈΡΠ΅ΡΠ½ΠΎΠ³ΠΎ ΡΡΠ°ΠΊΡΠ°, ΡΠ°ΡΠ΅ ΠΏΡΠ΅Π΄ΡΡΠ²Π»ΡΠ»ΠΈ ΠΆΠ°Π»ΠΎΠ±Ρ Π½Π° ΠΊΠΎΠ½ΡΠ°ΠΊΡΠ½ΡΠ΅ ΠΊΡΠΎΠ²ΠΎΡΠ΅ΡΠ΅Π½ΠΈΡ ΠΈ ΠΈΠΌΠ΅Π»ΠΈ ΠΎΡΡΠ³ΠΎΡΠ΅Π½Π½ΡΡ Π½Π°ΡΠ»Π΅Π΄ΡΡΠ²Π΅Π½Π½ΠΎΡΡΡ ΠΏΠΎ Π·Π»ΠΎΠΊΠ°ΡΠ΅ΡΡΠ²Π΅Π½Π½ΡΠΌ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΡΠΌ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ. ΠΡΠΈ ΠΊΠΎΠ»ΡΠΏΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠΈ Π²ΡΡΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ°ΡΠ΅ Ρ ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΎΠΊ Ρ ΠΏΠ΅ΡΡΠΈΡΡΠ΅Π½ΡΠΈΠ΅ΠΉ ΠΠΠ§ Π²ΡΡΠ²Π»ΡΠ΅ΡΡΡ ΠΏΡΠ½ΠΊΡΠ°ΡΠΈΡ ΠΈ ΠΉΠΎΠ΄Π½Π΅Π³Π°ΡΠΈΠ²Π½Π°Ρ Π·ΠΎΠ½Π°. Π£ΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ ΠΏΠ΅ΡΡΠΈΡΡΠ΅Π½ΡΠΈΠ΅ΠΉ ΠΠΠ§ Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ°ΡΠ΅ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΉ ΠΏΡΠΎΡΠ΅ΡΡ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ ΡΠΎΡΠ΅ΡΠ°Π»ΡΡ Ρ Π΄ΠΈΡΠΏΠ»Π°Π·ΠΈΠ΅ΠΉ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ. ΠΠΎΠ²ΡΡΠ΅Π½Π½Π°Ρ Π²ΠΈΡΡΡΠ½Π°Ρ Π½Π°Π³ΡΡΠ·ΠΊΠ° Π΄ΠΎΡΡΠΎΠ²Π΅ΡΠ½ΠΎ ΡΠ°ΡΠ΅ Π±ΡΠ»Π° ΠΎΡΠΌΠ΅ΡΠ΅Π½Π° Ρ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ ΠΏΠ΅ΡΡΠΈΡΡΠΈΡΡΡΡΠ΅ΠΉ ΠΠΠ§-ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ, ΠΏΡΠΈ ΡΡΠΎΠΌ ΠΏΠ΅ΡΡΠΈΡΡΠ΅Π½ΡΠΈΡ Π½Π°Π±Π»ΡΠ΄Π°Π»Π°ΡΡ Ρ Π±ΠΎΠ»ΡΠ½ΡΡ
Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ Π²ΠΎΡΠΏΠ°Π»ΠΈΡΠ΅Π»ΡΠ½ΡΠΌ ΠΏΡΠΎΡΠ΅ΡΡΠΎΠΌ ΡΠ΅ΠΉΠΊΠΈ ΠΌΠ°ΡΠΊΠΈ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ Ρ 18 ΡΠΈΠΏΠΎΠΌ ΠΠΠ§
Clinico-immunological substantiation immunotropic therapy of chronic cervicitis associated with HPV infection
A comprehensive survey of 48 women with chronic cervicitis associated with HPV β infection. The aim of this study was to determine the clinical and immunological effectiveness of complex therapy in patients with chronic servicitis associated with HPV infection, using of immunologic drug Likopid. To achieve the goal from all the women were divided into two groups. The first group consisted of 23 patients who received only basic therapy, the second group included 25 women, who in addition to basic therapy was using the drug Β«LikopidΒ». Control group consisted of 20 women who, with clinical, kolposkopicgical, morphological and molecular biological studies have not been identified changes in the cervix. To characterize the mechanisms of local antiinfection defense system was investigated cervical mucus in women of both groups before and after treatment. In cervical secret determined the total number of leukocytes and the percentage of viable cells, lysosomal, NST, and phagocytic activity of neutrophils. Thus, the study found that use of immunotropic therapy in treatment of chronic cervicitis associated with HPV β infection, increases the effectiveness of therapy leads to normalization of the local cellular immunity and eradication of human papilloma virus in 92% of cases.ΠΡΠΎΠ²Π΅Π΄Π΅Π½ΠΎ ΠΎΠ±ΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΠ΅ 48 ΠΆΠ΅Π½ΡΠΈΠ½ Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ΅ΡΠ²ΠΈΡΠΈΡΠΎΠΌ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ Ρ ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΠ°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ. Π¦Π΅Π»ΡΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΠ²ΠΈΠ»ΠΎΡΡ ΠΈΠ·ΡΡΠ΅Π½ΠΈΠ΅ ΠΊΠ»ΠΈΠ½ΠΈΠΊΠΎ-ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΉ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ ΠΆΠ΅Π½ΡΠΈΠ½ Ρ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΈΠΌ ΡΠ΅ΡΠ²ΠΈΡΠΈΡΠΎΠΌ, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΡΠΌ Ρ ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΠ°Π²ΠΈΡΡΡΠ½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ Ρ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ΠΌ ΠΈΠΌΠΌΡΠ½ΠΎΠΊΠΎΡΡΠΈΠ³ΠΈΡΡΡΡΠ΅Π³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° Β«ΠΠΈΠΊΠΎΠΏΠΈΠ΄Β». Π ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠΈ Ρ ΠΏΠΎΡΡΠ°Π²Π»Π΅Π½Π½ΠΎΠΉ ΡΠ΅Π»ΡΡ Π²ΡΠ΅ Π±ΠΎΠ»ΡΠ½ΡΠ΅ Π±ΡΠ»ΠΈ ΡΠ°Π·Π΄Π΅Π»Π΅Π½Ρ Π½Π° Π΄Π²Π΅ Π³ΡΡΠΏΠΏΡ. ΠΠ΅ΡΠ²ΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 23 ΠΏΠ°ΡΠΈΠ΅Π½ΡΠΊΠΈ, ΠΊΠΎΡΠΎΡΡΠ΅ ΠΏΠΎΠ»ΡΡΠ°Π»ΠΈ ΡΠΎΠ»ΡΠΊΠΎ Π±Π°Π·ΠΈΡΠ½ΡΡ ΡΠ΅ΡΠ°ΠΏΠΈΡ, Π²ΠΎ Π²ΡΠΎΡΡΡ Π³ΡΡΠΏΠΏΡ Π²ΠΎΡΠ»ΠΈ 25 ΠΆΠ΅Π½ΡΠΈΠ½, Ρ ΠΊΠΎΡΠΎΡΡΡ
ΠΏΠΎΠΌΠΈΠΌΠΎ Π±Π°Π·ΠΈΡΠ½ΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ Π±ΡΠ»Π° ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π° ΠΈΠΌΠΌΡΠ½ΠΎΠΊΠΎΡΡΠ΅ΠΊΡΠΈΡ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠΎΠΌ Β«ΠΠΈΠΊΠΎΠΏΠΈΠ΄Β». ΠΠΎΠ½ΡΡΠΎΠ»ΡΠ½ΡΡ Π³ΡΡΠΏΠΏΡ ΡΠΎΡΡΠ°Π²ΠΈΠ»ΠΈ 20 ΠΆΠ΅Π½ΡΠΈΠ½, Ρ ΠΊΠΎΡΠΎΡΡΡ
ΠΏΡΠΈ ΠΊΠ»ΠΈΠ½ΠΈΡΠ΅ΡΠΊΠΎΠΌ, ΠΊΠΎΠ»ΡΠΏΠΎΡΠΊΠΎΠΏΠΈΡΠ΅ΡΠΊΠΎΠΌ, ΠΌΠΎΡΡΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΈ ΠΌΠΎΠ»Π΅ΠΊΡΠ»ΡΡΠ½ΠΎ-Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΎΠΌ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡΡ
Π½Π΅ Π±ΡΠ»ΠΈ Π²ΡΡΠ²Π»Π΅Π½Ρ ΠΈΠ·ΠΌΠ΅Π½Π΅Π½ΠΈΡ Π² ΡΠ΅ΠΉΠΊΠ΅ ΠΌΠ°ΡΠΊΠΈ. ΠΠ»Ρ Ρ
Π°ΡΠ°ΠΊΡΠ΅ΡΠΈΡΡΠΈΠΊΠΈ Π»ΠΎΠΊΠ°Π»ΡΠ½ΡΡ
ΠΌΠ΅Ρ
Π°Π½ΠΈΠ·ΠΌΠΎΠ² ΠΏΡΠΎΡΠΈΠ²ΠΎΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΠΎΠΉ Π·Π°ΡΠΈΡΡ ΠΏΠΎΠ»ΠΎΠ²ΠΎΠΉ ΡΠΈΡΡΠ΅ΠΌΡ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π»ΠΈ ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΡΡ ΡΠ»ΠΈΠ·Ρ Ρ ΠΆΠ΅Π½ΡΠΈΠ½ ΠΎΠ±Π΅ΠΈΡ
Π³ΡΡΠΏΠΏ Π΄ΠΎ ΠΈ ΠΏΠΎΡΠ»Π΅ Π»Π΅ΡΠ΅Π½ΠΈΡ. Π ΡΠ΅ΡΠ²ΠΈΠΊΠ°Π»ΡΠ½ΠΎΠΌ ΡΠ΅ΠΊΡΠ΅ΡΠ΅ ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΠ»ΠΈ ΠΎΠ±ΡΠ΅Π΅ ΠΊΠΎΠ»ΠΈΡΠ΅ΡΡΠ²ΠΎ Π»Π΅ΠΉΠΊΠΎΡΠΈΡΠΎΠ² ΠΈ ΠΏΡΠΎΡΠ΅Π½Ρ ΠΆΠΈΠ·Π½Π΅ΡΠΏΠΎΡΠΎΠ±Π½ΡΡ
ΠΊΠ»Π΅ΡΠΎΠΊ; Π»ΠΈΠ·ΠΎΡΠΎΠΌΠ°Π»ΡΠ½ΡΡ, ΠΠ‘Π’- ΠΈ ΡΠ°Π³ΠΎΡΠΈΡΠ°ΡΠ½ΡΡ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ Π½Π΅ΠΉΡΡΠΎΡΠΈΠ»ΠΎΠ². Π’Π°ΠΊΠΈΠΌ ΠΎΠ±ΡΠ°Π·ΠΎΠΌ, Π² ΡΠ΅Π·ΡΠ»ΡΡΠ°ΡΠ΅ ΠΏΡΠΎΠ²Π΅Π΄Π΅Π½Π½ΠΎΠ³ΠΎ ΠΈΡΡΠ»Π΅Π΄ΠΎΠ²Π°Π½ΠΈΡ ΡΡΡΠ°Π½ΠΎΠ²Π»Π΅Π½ΠΎ, ΡΡΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΠΎΠ²Π°Π½ΠΈΠ΅ ΠΈΠΌΠΌΡΠ½ΠΎΡΡΠΎΠΏΠ½ΠΎΠ³ΠΎ ΠΏΡΠ΅ΠΏΠ°ΡΠ°ΡΠ° Β«ΠΠΈΠΊΠΎΠΏΠΈΠ΄Β» Π² ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ½ΠΎΠΌ Π»Π΅ΡΠ΅Π½ΠΈΠΈ Ρ
ΡΠΎΠ½ΠΈΡΠ΅ΡΠΊΠΎΠ³ΠΎ ΡΠ΅ΡΠ²ΠΈΡΠΈΡΠ°, Π°ΡΡΠΎΡΠΈΠΈΡΠΎΠ²Π°Π½Π½ΠΎΠ³ΠΎ Ρ ΠΠΠ§ β ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠ΅ΠΉ, ΠΏΠΎΠ²ΡΡΠ°Π΅Ρ ΡΡΡΠ΅ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΏΡΠΎΠ²ΠΎΠ΄ΠΈΠΌΠΎΠΉ ΡΠ΅ΡΠ°ΠΏΠΈΠΈ, ΠΏΡΠΈΠ²ΠΎΠ΄ΠΈΡ ΠΊ Π½ΠΎΡΠΌΠ°Π»ΠΈΠ·Π°ΡΠΈΠΈ ΠΊΠ»Π΅ΡΠΎΡΠ½ΡΡ
ΡΠ°ΠΊΡΠΎΡΠΎΠ² Π»ΠΎΠΊΠ°Π»ΡΠ½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ° ΠΈ ΡΡΠ°Π΄ΠΈΠΊΠ°ΡΠΈΠΈ Π²ΠΈΡΡΡΠ° ΠΏΠ°ΠΏΠΈΠ»Π»ΠΎΠΌΡ ΡΠ΅Π»ΠΎΠ²Π΅ΠΊΠ° Π² 92% ΡΠ»ΡΡΠ°Π΅Π²
Hyper-heuristics for structure and parameters tuning in evolutionary algorithms
Π’Π΅ΠΊΡΡ ΡΡΠ°ΡΡΠΈ Π½Π΅ ΠΏΡΠ±Π»ΠΈΠΊΡΠ΅ΡΡΡ Π² ΠΎΡΠΊΡΡΡΠΎΠΌ Π΄ΠΎΡΡΡΠΏΠ΅ Π² ΡΠΎΠΎΡΠ²Π΅ΡΡΡΠ²ΠΈΠΈ Ρ ΠΏΠΎΠ»ΠΈΡΠΈΠΊΠΎΠΉ ΠΆΡΡΠ½Π°Π»Π°